Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2559 of 5804
-
Can muscle strength predict lung cancer survival?
Knowledge-focused ENROLLING_BY_INVITATIONThe PHILICA study investigates whether muscle mass, muscle strength, and muscle function are associated with treatment tolerance, quality of life and survival in patients with lung cancer. It also aims to explore why some patients face challenges in completing their treatment. Th…
Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New combo inhaler aims to ease asthma symptoms
Disease control Recruiting nowThe primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To…
Phase: PHASE3 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can brain wiring predict opioid relapse? yale launches 240-Person study
Knowledge-focused Recruiting nowThis project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New hope for advanced cancer: first human trial of SIGX1094R begins
Disease control Recruiting nowThis is a phase I clinical, first-in-human study of SIGX1094R monotherapy. The goal of this trial is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), anti-tumor activity and food effect of SIGX1094R in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Signet Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a blood flow cuff help disabled people build muscle without heavy lifting?
Symptom relief Recruiting nowA large portion of the American population live with disabilities. People with disabilities can find it difficult to perform standard exercise routines. Regular exercise is necessary to be healthy, especially as people age. Lack of exercise can lead to secondary health concerns, …
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New test may predict immunotherapy success in bladder cancer
Knowledge-focused Recruiting nowFirst-line systemic treatments for bladder cancer are based on a combination of cytotoxic and immunotherapy, sequentially or concomitantly. Immune checkpoint inhibition (ICPI) is a powerful treatment for patients with metastatic urothelial carcinoma (UC). Since 2017, pembrolizuma…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Gut bacteria tweak may curb weight regain
Knowledge-focused Recruiting nowThis past century witnessed a significant increase in the prevalence of obesity. Successful weight loss maintenance is defined as losing at least 10% of the initial body weight and maintaining it for at least one year. However, keeping a low body weight is rarely maintained, as 8…
Phase: NA • Sponsor: Weizmann Institute of Science • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Exercise eases endometriosis: new study shows promise
Symptom relief CompletedThere is no specific treatment for endometriosis, because the pathophysiology is poorly understood. Adapted physical activity (APA) is recognized as a beneficial supportive care for patients suffering from chronic pathology. Adapted physical activity can play a role in managing …
Phase: NA • Sponsor: University Hospital Center of Martinique • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo takes on Hard-to-Treat cancers in first human test
Disease control Recruiting nowThis is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study of HM16390, as a single agent and in combination with pembrolizumab to assess safety, tolerability, MTD, RP2D, PK, and efficacy in patients with advanced or metastatic solid tumors. Dose-Escalation Part …
Phase: PHASE1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Researchers dig into past records to find clues for melanoma immunotherapy success
Knowledge-focused Recruiting nowAlthough impressive progress has been made with this new therapeutic strategy, only a proportion of patients achieve a complete and sustained response. Studies have already identified predictive factors of treatment response that are now widely recognized. In this study, the inve…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Could zapping the brain and spine together boost recovery?
Knowledge-focused Recruiting nowThe goal of this clinical study is to investigate the potential synergy between non-invasive brain and spinal cord stimulation administered during a cognitive-motor task, in terms of their immediate effects on sensorimotor and cognitive functions after neurological injuries affec…
Phase: PHASE2 • Sponsor: Centre National de la Recherche Scientifique, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Can better sleep help people with chronic pain use fewer opioids?
Symptom relief Recruiting nowThe goal of this study is to test two behavioral interventions for chronic insomnia in individuals with chronic pain and use prescribed opioid medication to treat their chronic pain.
Phase: NA • Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Your voice may tell if You're using opioids – new study says yes!
Knowledge-focused CompletedThis study explored whether changes in a person's voice could help identify opioid use in patients with opioid use disorder (OUD). Current methods for determining whether a patient is intoxicated or in withdrawal often rely on self-reporting and clinical judgment, which can be su…
Sponsor: Tenvos Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Radioactive tracer could spot hidden breast cancer tumors
Diagnosis CompletedA phase 1 imaging study of 68Ga-R10602 in hormone-receptor positive breast cancer.
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
New laser could keep melasma from coming back
Disease control OngoingMelasma is a frequently acquired hyperpigmentary disorder affecting up to 30% of child-bearing women in some populations. Melasma is still often called chloasma or the pregnancy mask and is considered as the main consequence of female hormone stimulation on a predisposed genetic …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Johns hopkins launches study to uncover hidden cause of right heart failure
Knowledge-focused Recruiting nowRight ventricular (RV) failure is recognized to worsen patient outcomes in the setting of heart failure with reduced ejection fraction (HFrEF)-related pulmonary hypertension (PH), yet the investigators fall short in trying to identify and treat it. The current proposal will (1) d…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Which breast implant survives radiation best? study seeks answers
Knowledge-focused CompletedThe purpose of this multicenter retrospective cohort study is to determine the effect of radiotherapy on capsular contraction and implant loss rates in patients undergoing prepectoral immediate implant-based breast reconstruction (IBBR) comparing Polyurethan (PU) and non-PU cover…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New hip fracture plate could speed healing
Disease control Recruiting nowTo verify the safety and efficacy of sliding compression locking plates in the treatment of fresh femoral neck fractures
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
VR headsets could slash opioid use after surgery
Symptom relief Recruiting nowThis clinical trial aims to evaluate the efficacy of virtual reality (VR) as an adjunctive therapeutic method to reduce opioid consumption during the postoperative period of cardiac and thoracic surgeries. Conducted at InCor/HCFMUSP, this single-center, prospective, randomized tr…
Phase: NA • Sponsor: Filomena R B G Galas • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Mindfulness may shield aging brains from Alzheimer's
Prevention Recruiting nowThe primary objective of the proposed research is to investigate the promise and underlying mechanisms of mindfulness training as a preventative lifestyle intervention to enhance cognitive health in Latino older adults, thereby mitigating risk of Alzheimer's Disease (AD) in a pop…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC